AAAAAA
Results: 26-50/83
Authors:
SCHERNTHANER G
WEIN W
SANDHOLZER K
EQUILUZBRUCK S
BIRKETT M
Citation: G. Schernthaner et al., POSTPRANDIAL INSULIN LISPRO - A NEW OPTION IN TYPE-I DIABETIC-PATIENTS, Diabetes, 46, 1997, pp. 388-388
Authors:
SCHMOLZER B
MENZEL EJ
FESTA A
SCHERNTHANER G
Citation: B. Schmolzer et al., DIFFERENTIAL RECEPTOR EXPRESSION FOR ADVANCED GLYCATED END-PRODUCTS (AGES) ON MONOCYTES IN IDDM PATIENTS, Diabetes, 46, 1997, pp. 389-389
Authors:
SCHMOLZER B
FESTA A
SCHERNTHANER G
MENZEL EJ
Citation: B. Schmolzer et al., DETECTION OF AGE-PEPTIDES IN SERUM OF IDDM PATIENTS BY A NEWLY DEVELOPED ELISA USING AGE-MODIFIED FIBRONECTIN-PEPTIDES, Diabetes, 46, 1997, pp. 390-390
Authors:
SCHERNTHANER G
BIESENBACH G
KACEROVSKY G
MIHALJEVIC R
PIEBER TR
Citation: G. Schernthaner et al., EVALUATION OF COMBINATION THERAPY IN NIDDM PATIENTS WITH SULFONYLUREAFAILURE - THE AUSTRIAN INSULIN INTERVENTION STUDY, Diabetes, 46, 1997, pp. 643-643
Authors:
SCHMOLZER B
FESTA A
SENGOELGE G
SCHERNTHANER G
MENZEL EJ
Citation: B. Schmolzer et al., IMMUNOADSORPTION METHODS FOR REMOVAL OF AGES IN SERUM, Journal of the American Society of Nephrology, 7(9), 1996, pp. 2364-2364
Authors:
EQUILUZBRUCK S
SCHNACK C
KOPP HP
SCHERNTHANER G
Citation: S. Equiluzbruck et al., NONDIPPING OF NOCTURNAL BLOOD-PRESSURE IS RELATED TO URINARY ALBUMIN EXCRETION RATE IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS, American journal of hypertension, 9(11), 1996, pp. 1139-1143
Authors:
BAGHESTANIAN M
BANKL HC
SILLABER C
BEIL WJ
RADASZKIEWICZ T
FUREDER W
PREISER J
VESELY M
SCHERNTHANER G
LECHNER K
VALENT P
Citation: M. Baghestanian et al., A CASE OF MALIGNANT MASTOCYTOSIS WITH CIRCULATING MAST-CELL PRECURSORS - BIOLOGIC AND PHENOTYPIC CHARACTERIZATION OF THE MALIGNANT CLONE, Leukemia, 10(1), 1996, pp. 159-166
Authors:
KOPP HP
FESTA A
HOPMEIER P
SCHERNTHANER G
Citation: Hp. Kopp et al., EVALUATION OF A NEW METHOD FOR MEASUREMEN T OF GLYCATED HEMOGLOBIN WITH MONOCLONAL-ANTIBODIES, Wiener Klinische Wochenschrift, 108(1), 1996, pp. 16-19
Authors:
SCHNACK C
FESTA A
SCHWARZMAIERDASSIE A
HABER P
SCHERNTHANER G
Citation: C. Schnack et al., PULMONARY DYSFUNCTION IN TYPE-1 DIABETES IN RELATION TO METABOLIC LONG-TERM CONTROL AND TO INCIPIENT DIABETIC NEPHROPATHY, Nephron, 74(2), 1996, pp. 395-400
Authors:
FESTA A
MERIO R
BERGMANN H
WEBER U
SCHNEIDER C
SCHERNTHANER G
STACHER G
Citation: A. Festa et al., DOES RAPID GASTRIC-EMPTYING PREVAIL IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Gastroenterology, 110(4), 1996, pp. 663-663
Authors:
SCHNACK C
HOFFMANN W
HOPMEIER P
SCHERNTHANER G
Citation: C. Schnack et al., RENAL AND METABOLIC EFFECTS OF 1-YEAR TREATMENT WITH RAMIPRIL OR ATENOLOL IN NIDDM PATIENTS WITH MICROALBUMINURIA, Diabetologia, 39(12), 1996, pp. 1611-1616
Authors:
SCHERNTHANER G
WEIN W
SANDHOLZER K
EQUILUZBRUCK S
BIRKETT M
Citation: G. Schernthaner et al., POSTPRANDIAL USE OF INSULIN LISPRO - A NEW THERAPEUTIC OPTION IN THE TREATMENT OF TYPE-1 DIABETIC-PATIENTS, Diabetologia, 39, 1996, pp. 85-85
Authors:
SCHNACK C
BIESENBACH G
KACEROVSKY G
MIHALJEVIC R
PECNIK I
PIEBER T
SCHERNTHANER G
Citation: C. Schnack et al., EVALUATION OF OPTIMAL THERAPY IN TYPE-2 DIABETIC-PATIENTS INSUFFICIENTLY TREATED WITH SULFONYLUREAS - THE AUSTRIAN INSULIN INTERVENTION STUDY, Diabetologia, 39, 1996, pp. 116-116
Authors:
FESTA A
SCHMOLZER B
MENZEL EJ
SCHERNTHANER G
Citation: A. Festa et al., MONOCYTE RECEPTORS FOR ADVANCED GLYCOSYLATION ENDPRODUCTS IN PATIENTSWITH TYPE-1 DIABETES-MELLITUS, Diabetologia, 39, 1996, pp. 523-523
Authors:
KREXNER E
HOPMEIER P
SCHERNTHANER G
Citation: E. Krexner et al., SERUM FERRITIN AND IRON-METABOLISM IN TYPE-2 DIABETIC-PATIENTS TREATED WITH DIET, ORAL HYPOGLYCEMIC AGENTS OR INSULIN, Diabetologia, 39, 1996, pp. 796-796
Authors:
KOPP HP
MELANDER A
KRUGLUGER W
HOPMEIER P
SCHERNTHANER G
Citation: Hp. Kopp et al., ABSORPTION OF SULFONYLUREA DRUGS IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS, Diabetologia, 39, 1996, pp. 872-872
Authors:
MENZEL EJ
FESTA A
KOPP HP
SCHERNTHANER G
Citation: Ej. Menzel et al., AUTOANTIBODIES AGAINST OXIDIZED LOW-DENSITY LIPOPROTEINS PATIENTS WITH TYPE-1 DIABETES-MELLITUS, Diabetologia, 39, 1996, pp. 1067-1067
Authors:
EIBL N
SCHNACK C
FRANK M
SCHERNTHANER G
Citation: N. Eibl et al., PROGRESSION OF ADVANCED MICROALBUMINURIA IN NORMOTENSIVE TYPE-2 DIABETIC-PATIENTS DESPITE IMPROVED METABOLIC CONTROL, Diabetologia, 39, 1996, pp. 1172-1172
Authors:
SCHERNTHANER G
FEIG P
HANEFELD M
PETZINNA D
RAPTIS S
RYBKA J
STANDL E
Citation: G. Schernthaner et al., COMPARISON OF MIGLITOL AND METFORMIN IN NIDDM PATIENTS NOT RESPONDINGSUFFICIENTLY TO SULFONYLUREA, Diabetes, 45, 1996, pp. 445-445
Authors:
SCHULLER J
CZEJKA M
BANDAK S
BOROW D
PIETRZAK C
MAREI I
SCHERNTHANER G
Citation: J. Schuller et al., COMPARISON OF PHARMACOKINETICS (PK) OF FREE AND LIPOSOME-ENCAPSULATEDDOXORUBICIN IN ADVANCED CANCER-PATIENTS, European journal of cancer, 31A, 1995, pp. 959-959
Authors:
KOPP HP
KRUGLUGER W
FESTA A
SCHERNTHANER G
Citation: Hp. Kopp et al., THE CLINICAL RELEVANCE OF FETAL HEMOGLOBIN IN IDDM AND NIDDM PATIENTS, Diabetes care, 18(6), 1995, pp. 883-884
Authors:
EIBL NL
KOPP HP
NOWAK HR
SCHNACK CJ
HOPMEIER PG
SCHERNTHANER G
Citation: Nl. Eibl et al., HYPOMAGNESEMIA IN TYPE-II DIABETES - EFFECT OF A 3-MONTH REPLACEMENT THERAPY, Diabetes care, 18(2), 1995, pp. 188-192
Authors:
SCHERNTHANER G
Citation: G. Schernthaner, PROGRESS IN THE IMMUNOINTERVENTION OF TYPE-1 DIABETES-MELLITUS, Hormone and Metabolic Research, 27(12), 1995, pp. 547-554
Authors:
MERIO R
EIBL N
FESTA A
STACHERJANOTTA G
SCHNEIDER C
WEBER U
GAUPMANN G
BUDKA C
BERGMANN H
SCHERNTHANER G
STACHER G
Citation: R. Merio et al., INSULIN-DEPENDENT DIABETES-MELLITUS - GASTRIC-EMPTYING IN RELATION TOAUTONOMIC AND PERIPHERAL NEUROPATHY AND BLOOD-GLUCOSE, Gastroenterology, 108(4), 1995, pp. 648-648
Authors:
KOTZMANN H
LINKESCH M
LUDVIK B
CLODI M
LUGER A
SCHERNTHANER G
PRAGER R
KLAUSER R
Citation: H. Kotzmann et al., EFFECT OF DANAZOL-INDUCED CHRONIC HYPERGLUCAGONEMIA ON GLUCOSE-TOLERANCE AND TURNOVER, European journal of clinical investigation, 25(12), 1995, pp. 942-947